The Immune Response Corporation (OTCBB: IMNR) – Tuesday’s shares went up 0.53% to $0.019. 1,903,359 shares were traded. The Immune Response Corporation announced on Otober 30th that Dr. Joseph O’Neill, President and CEO, will present an overview of the Company’s immune-based therapies, currently in Phase II clinical trials, at the Rodman & Renshaw Eighth Annual Healthcare Conference in New York City. Dr. O’Neill will discuss a key strategic agreement, signed October 10, 2006, with Accelsiors CRO & Consultancy Services, a clinical research organization (CRO) with extensive experience in conducting multiple sclerosis (MS) trials, to oversee a 200-patient Phase IIb trial of NeuroVax(TM), an investigational T-cell receptor (TCR) peptide vaccine for the treatment of multiple sclerosis (MS). He will review in detail the Company’s drug development pipeline, and status of the Phase II clinical trials in progress for NeuroVax, and for IR103, for the treatment of human immunodeficiency virus (HIV). IR103 is based on the Company’s patented whole-inactivated virus technology, co-invented by Dr. Jonas Salk.
The Immune Response Corporation is an immuno-pharmaceutical company focused on developing products to treat autoimmune and infectious diseases. The Company’s lead immune-based therapeutic product candidates are NeuroVax™ for the treatment of MS and IR103 for the treatment of HIV infection. Both of these therapies are in Phase II clinical development and are designed to stimulate pathogen-specific immune responses aimed at slowing or halting the rate of disease progression.
ATSI Communications, Inc. (OTCBB: ATSX)
The Immune Response Corporation (OTCBB: IMNR) – Tuesday’s shares went up 3.45% to $0.30. The volume was 42,330. The Immune Response Corporation announced on Otober 30th that Dr. Joseph O’Neill, President and CEO, will present an overview of the Company’s immune-based therapies, currently in Phase II clinical trials, at the Rodman & Renshaw Eighth Annual Healthcare Conference in New York City. Dr. O’Neill will discuss a key strategic agreement, signed October 10, 2006, with Accelsiors CRO & Consultancy Services, a clinical research organization (CRO) with extensive experience in conducting multiple sclerosis (MS) trials, to oversee a 200-patient Phase IIb trial of NeuroVax(TM), an investigational T-cell receptor (TCR) peptide vaccine for the treatment of multiple sclerosis (MS). He will review in detail the Company’s drug development pipeline, and status of the Phase II clinical trials in progress for NeuroVax, and for IR103, for the treatment of human immunodeficiency virus (HIV). IR103 is based on the Company’s patented whole-inactivated virus technology, co-invented by Dr. Jonas Salk.
ATSI Communications, Inc. (OTCBB: ATSX) is a global Voice over Internet protocol (”VoIP”) communications Company based in San Antonio, Texas. The Company operates through its two wholly owned subsidiaries, Digerati Networks, Inc. and Telefamilia Communications, Inc. ATSI also owns a minority interest of a subsidiary in Mexico, ATSI Comunicaciones, S.A. de C.V., which operates under a 30-year government issued telecommunications license similar to those owned by AT&T’s and MCI’s subsidiaries in Mexico. ATSI is focused on serving high-growth international markets with an emphasis on the Latin American region. ATSI’s primary market, Mexico, is the top producer of voice communications traffic with the U.S., making it the most lucrative telecommunications corridor in the world in terms of revenue. Some of the catalysts fueling growth throughout Latin America include the rapid expansion of the Hispanic population in the U.S., the increase in travel between Latin American countries and the U.S., the build-out of local telecommunications networks resulting in an increase in teledensity in Latin countries, and the proliferation of communication devices throughout the region. The Company’s customer base includes a variety of carriers, including top tier providers and emerging operators that generate voice traffic to and from the markets served by ATSI.
IQ Webquest, Inc. (OTC: IQWB)
IQ Webquest, Inc. (OTC: IQWB) – Tuesday’s shares stayed even at $1.75. No shares were traded. I.Q. Webquest Inc. announced on October 31st that the results of the previous weekend’s promotion were so promising the Company decided to increase the free subscriptions of its online dating network, TheUltimateDatingSite.Com from 5,000 to 10,000. The Company is offering a free 12 month subscription to the next 10,000 subscribers who sign up starting October 27, 2006. The annual subscription fee of $99.00 will be waived and the subscribers will receive all of the benefits of the highest level paid subscription for free for the next 12 months. With a successful Beta test of the social networking platform, the company believes that the network is fully operational. With this in mind and with the excitement of the free memberships, the company has increased the free memberships to 10,000.
IQ Webquest, Inc. (OTC: IQWB) strives to become the leader in the multibillion dollar social networking industry through a diverse portfolio of websites currently under development. The company will attract substantial revenue primarily through advertising and memberships. The sites will take advantage of economies of scale and other synergies including cross promotion, membership reciprocities, and niche expansion. IQ Webquest offers a dating service for single men and women, ages 18 and up. IQ Webquest is a safe place for singles to talk with one another, find common values, and arrange to meet each other face to face. Each member has the ability to view all member profiles and provide information to their profile at their own discretion. To enhance the experience, members can choose to upload pictures and audio/video streams of themselves. Once members find someone of interest, he/she can introduce himself/herself through electronic correspondence.
EnXnet Inc. (OTCBB: EXNT)
EnXnet Inc. (OTCBB: EXNT) – Tuesday’s shares increased 7.44% to $1.30. 18,350 was the volume. EnXnet, Inc. announced on November 2nd that they increased their ownership from a 25% to a 35% equity position in Medical D-Tect-OR, LLC by assigning their patent rights for a system to detect foreign objects inside the human body during operations. BAHF, LLC retains 65% equity interest in the joint venture company – Medical D-Tect-OR, LLC. EnXnet’s solution may revolutionize operating room procedures around the world, potentially saving thousands of lives and avoiding otherwise unnecessary additional medical procedures. A working version of this technology has already been displayed and proven. However, Medical-D-Tect-OR, LLC will be demonstrating a more user-friendly working prototype to the medical industry in the near future. “The joint venture with the BAHF is really exciting,” said Ryan Corley, CEO of EnXnet. “They bring a wealth of marketing and distribution expertise to Medical D-Tect-OR.”
EnXnet, Inc. is a company that spent its early years finding and developing new technologies with great potential for making valuable impacts in the multimedia environment. EnXnet’s unique products offer their clientele new methods to deter theft, improve listening and viewing experiences, and present information in exciting interactive formats. These technologies and related products, while at the leading edge in their respective applications, are affordable and provide needed solutions to multiple problems. Founded by Ryan Corley in 1999 and based based in Tulsa, Oklahoma as Southern Wireless, Inc., the company changed its name to eMajix.com, Inc. in 2000 and further changed to EnXnet, Inc. in 2001. EnXnet’s mission is to provide their customers with efficient and economic solutions to meet their needs. These solutions range from EnXnet’s OneDisc™/DVDPlus©, which provides DVD and CD formats on opposite sides of one disc for the convenience of the listener/viewer; to their DSTag™ which provides theft deterrents molded into optical disc products and their RFID Deactivation Device which solves personal privacy issues with RFID tracking and theft deterrent tags; to EnXmedia® which provides their clients a one-stop source for their electronic media needs; and ClearVideo® compression which drastically increases the media storage capability of CDs.
Rotoblock (OTCBB: ROTB)
Rotoblock Corporation (OTCBB: ROTB) – Tuesday’s shares stayed even at $0.09. 5,500 shares were traded. Rotoblock announced on October 25th that it won an extension to own and market the Oscillating Piston Engine; a unique and highly advanced internal engine that will give automobiles, airplanes, boats and many other mobile and stationery applications much more power. Rotoblock has spent the last several months negotiating terms to the patent rights and has now signed a 37 month extension agreement which gives Rotoblock extended exclusive rights on the powerful technology. According to Rotoblock President, Matthias Heinze, “We are thrilled for what it means to the health of our company. Now that we are no longer on hold waiting for this extention, we will immediately exploit new markets such as China and India where we know our technology is in high demand. Every indication shows that the Oscillating Piston Engine should surpass performance of current combustion engines on several levels. It is expected to become very popular in the automotive, aviation and marine markets.”
Rotoblock Corporation, through its wholly owned subsidiary, Rotoblock Inc., is an engineering/research company dedicated to the development of Oscillating Piston Engine. Rotoblock is focused on the continued development and improvement of the Oscillating Piston Engine to the state where its mechanical, ecological and economic viability leads to the profitable licensing of the manufacturer’s rights to a proprietary patented design or a partnership for its manufacture. The Company was incorporated in Nevada, and is headquartered in Santa Rosa, California. The Company has full rights to the patents of the original Oscillating Piston Engine and believes the Rotoblock Oscillating Piston Engine has particular and useful applications in developing countries such as China and India and will be including these areas in the marketing and commercialization phase of this engine.
Northamerican Energy Group Corp. (OTC: NNYG)
Northamerican Energy Group Corp. (OTC: NNYG) – Tuesday’s shares closed down 39.13% to $0.014. The volume was 98,700. Northamerican Energy Group Corporation announced on October 24th that it executed an exclusive option with Penergy, of Midland, Texas, to purchase the leases on 1,920 acres encompassing the South Leonard (Queen/Penrose) and Rhodes (Yates/Seven Rivers) Fields in Lea County, New Mexico. These leases have 30 existing wells originally drilled by Tenneco into shallow (under 3000′) reservoirs, with just one of the existing wells currently operating out of the Yates formation; however many of the remaining 29 wells that were temporarily shut in can easily be reworked, at nominal cost, to bring them back on line with anticipated production of 5-10 Blpd of oil, and 50-100 Mcfd of natural gas. The 3-D Seismic, and geological surveys, of both these leases, and in adjacent leases east, and northeast of these leases show good promise and potential in the Devonian (9200′) and EllenBurger (11,700′) zones, as verified by initial natural gas potential of 1555 Mcfpd, 1668 Mcfpd and 4249 Mcfpd in the offsetting wells, as shown in the production reports of the east coast petroleum producer that drilled them.
Northamerican Energy Group Corp. specializes in acquiring Oil and Gas leases with proven reserves that have the potential for increased oil and natural gas production utilizing the new well production stimulation systems currently available. Northamerican’s main objective is to locate and acquire Oil and Gas Leases with upside potential for enhanced recovery and to accomplish this by employing: new and vastly improved chemical treatments for treating existing wells, acquisitions where the full potential of the lease has never been properly exploited, well workovers that utilize new equipment and technology, developmental drilling programs to drill new wells into existing proven reserves, and chemical fracture stimulation systems to improve production.
We Invite you to Visit the All New StockGuru Blog!
Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks.
Click HERE to visit the Blog, or go to:
http://stockguru.com/blog/
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 453-4268. Web: StockGuru.com. Email: Publisher@stockguru.com. IMNR Disclosure: Pentony Enterprises LLC was compensated $50,000 from ROI Group Associates Inc. for profile coverage. ATSX Disclosure: Pentony Enterprises LLC was compensated $18,000 by the company for profile coverage. IQWB Disclosure: Pentony Enterprises LLC was compensated $21,000 from a non-controlling third party for profile coverage. EXNT Disclosure: Pentony Enterprises LLC was compensated $11,000 from a non-controlling third party for profile coverage. ROTB Disclosure: Pentony Enterprises LLC was compensated 250,000 free trading shares from a non-controlling third party for profile coverage. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this. NNYG Disclosure: Pentony Enterprises LLC was compensated 2,700,000 free trading shares from a non-controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.